Olaparib, a new hope for ovarian cancer

被引：0
|
作者：
Samoon, Zarka [1 ]
Jabbar, Adnan Abdul [1 ]
机构：
[1] Aga Khan Univ Hosp, Dept Oncol, Karachi, Pakistan
来源：
INDIAN JOURNAL OF CANCER | 2020年 / 57卷 / 03期
关键词：
MAINTENANCE THERAPY; PHASE-2; PARP;
D O I：
10.4103/ijc.IJC_1_19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [21] Safety evaluation of olaparib for treating ovarian cancer
    Lheureux, Stephanie
    Bowering, Valerie
    Karakasis, Katherine
    Oza, Amit M.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1305 - 1316
  • [22] Experience with the use of olaparib in patients with ovarian cancer
    Gallardo-Rincon, Dolores
    Alamilla-Garcia, Gabriela
    Montes-Servin, Edgar
    Morales-Vazquez, Flavia
    Cano-Blanco, Claudia
    Coronel-Martinez, Jaime
    Bahena-Gonzalez, Antonio
    Gerson-Cwilich, Raquel
    Isla-Ortiz, David
    Toledo-Leyva, Alfredo
    Montes-Servin, Elizabeth
    Michel-Tello, David
    Espinosa-Romero, Raquel
    GACETA MEDICA DE MEXICO, 2019, 155 (06): : 585 - 589
  • [23] Could cannabinoids provide a new hope for ovarian cancer patients?
    Kaur, Rimanee
    Javid, Farideh A. A.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (04):
  • [24] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
    Heo, Young-A
    Dhillon, Sohita
    TARGETED ONCOLOGY, 2018, 13 (06) : 801 - 808
  • [25] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
    Young-A Heo
    Sohita Dhillon
    Targeted Oncology, 2018, 13 : 801 - 808
  • [26] Olaparib, PARP1 inhibitor in ovarian cancer
    Marchetti, Claudia
    Imperiale, Ludovica
    Gasparri, Maria Luisa
    Palaia, Innocenza
    Pignata, Sandro
    Boni, Terenzio
    Bellati, Filippo
    Panici, Pierluigi Benedetti
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1575 - 1584
  • [27] OVARIAN CANCER Olaparib maintenance moves to first line
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 725 - 725
  • [28] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Ying Chen
    Lei Zhang
    Quan Hao
    Archives of Gynecology and Obstetrics, 2013, 288 : 367 - 374
  • [29] Olaparib and ovarian cancer-overall survival outcomes
    Kehoe, Sean
    LANCET ONCOLOGY, 2016, 17 (11): : 1474 - 1475
  • [30] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Chen, Ying
    Zhang, Lei
    Hao, Quan
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (02) : 367 - 374
12345